{
    "clinical_study": {
        "@rank": "72063", 
        "arm_group": [
            {
                "arm_group_label": "Ingenol Mebutate", 
                "arm_group_type": "Experimental", 
                "description": "Ingenol Mebutate applied to one side of face with skin lesions"
            }, 
            {
                "arm_group_label": "Cryotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Cryotherapy applied to other side of face with skin lesions"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out the effectiveness of ingenol mebutate compared to\n      cryotherapy (freezing of the tissue) for the treatment of face and scalp skin lesions."
        }, 
        "brief_title": "Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Actinic Keratosis", 
        "condition_browse": {
            "mesh_term": [
                "Keratosis", 
                "Keratosis, Actinic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female subjects between 18 and 89 years old.\n\n          -  Have at least a total of 10 non-hypertrophic actinic keratoses (AKs) on the face and\n             scalp\n\n          -  The subjects are in good health\n\n          -  The subjects have the willingness and the ability to understand and provide informed\n             consent for the use of their tissue and are able to communicate with the investigator\n\n        Exclusion Criteria:\n\n          -  Subjects under 18 years of age and over the age of 89\n\n          -  Subjects who are pregnant or lactating\n\n          -  Subjects with sensitivity to cold\n\n          -  Subjects with use of topical medications such as corticosteroids, alpha-hydroxyacids\n             or retinoids 2 weeks before study entry\n\n          -  Subjects who received previous treatment of target AKs\n\n          -  Subjects whose target treatment area was within 5 cm of an incompletely healed wound\n             or within 10 cm of a suspected basal-cell or squamous-cell carcinoma\n\n          -  Subjects with use of medications or other treatments that could interfere with\n             evaluation of the treatment area within 2 months before study entry (e.g., topical\n             medications, artificial tanners, immunosuppressive medications, immunomodulating\n             agents, cytotoxic drugs, ultraviolet B phototherapy, other therapies for actinic\n             keratoses, or oral retinoids)\n\n          -  Subjects who are unable to understand the protocol or to give informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "89 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01735942", 
            "org_study_id": "STU68227"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ingenol Mebutate", 
                "intervention_name": "Ingenol mebutate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cryotherapy", 
                "intervention_name": "cryotherapy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern University Feinberg School of Medicine, Department of Dermatology"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Comparison of Ingenol Mebutate and Cryotherapy for Treatment of Actinic Keratoses.", 
        "overall_official": {
            "affiliation": "Northwestern University", 
            "last_name": "Murad Alam, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The visual assessment evaluates seven clinical signs: erythema, edema, wheal vesiculation, ulceration, hemorrhage, purpura, and crusting.  Each sign is assigned a score of 0 to 3, where a score of 0 is associated with no expression of the clinical sign and a better outcome, and a score of 3 is associated with severe expression of the clinical sign and a worse outcome.", 
            "measure": "Change from baseline in visual assessment scores at 3 months", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01735942"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northwestern University", 
            "investigator_full_name": "Murad Alam", 
            "investigator_title": "Professor in Dermatology, Otolaryngology- Head and Neck Surgery and Surgery-Organ Transplantation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}